FDA WORKING GROUP ON WOMEN/MINORITIES IN CLINICAL TRIALS TO MAKE RECOMMENDATION BY SUMMER; GUIDANCE FOR INDUSTRY PLANNED ON NOTICE OF DISCONTINUATION
Executive Summary
FDA will issue a guidance to industry on the notification requirements for discontinuance of the manufacture of a product outlined in the FDA Modernization Act of 1997.